A case of nizatidine induced cholestatic hepatitis.
- Author:
Jae Pil YUN
1
;
Sung Ki AHN
;
Dae Keun PYUN
;
Seong Su NAH
;
Jae Il KIM
;
Jung Min CHOI
;
Young Suk LIM
Author Information
1. Department of Internal Medicine, Asan Medicine Center, University of Ulsan College of Medicine, Seoul, Korea. limys@amc.seoul.kr
- Publication Type:Case Report
- Keywords:
Nizatidine;
Cholestasis;
Hepatitis
- MeSH:
Bilirubin;
Biopsy, Needle;
Cholestasis;
Female;
Hepatitis*;
Histamine;
Humans;
Jaundice;
Laryngitis;
Liver;
Nizatidine*
- From:Korean Journal of Medicine
2005;69(5):545-548
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Histamine H2-receptor antagonists are commonly used in many clinical conditions, and their hepatotoxicity has been reported occasionally.However, cholestatic hepatitis induced by nizatidine is very rare. Here, we report a young female patient with severe cholestatic hepatitis associated with nizatidine use. She had taken nizatidine to manage asymptomatic reflux laryngitis by an otonasolaryngology doctorfor about 20 days. After about 15 days of nizatidine administration, jaundice developed and continued for more than2 months withmaximal serum total bilirubin reaching 17.5 mg/dL, in spite of the discontinuation of medication. Liver specimen obtained by needle biopsy revealed severe centrilobular cholestatic hepatitis. Her liver function improved slowly and serum total bilirubin decreased down to 1.7 mg/dL after months later from the development of jaundice. As far as our knowledge, this is the second case of nizatidine- induced cholestatic hepatitis reported in the literature.
